4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001628280-22-014963
Chief Financial Officer acquired 32,121 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shah Mihir Chief Financial Officer | 2022-05-19 | Grant or award | +32,121 | 32,121 | D | ||
| Derivatives | |||||||
| Shah Mihir Chief Financial Officer | 2022-05-19 | Grant or award · Stock Options (right to buy) | +163,039 | 163,039 | D | ||
Loading xslF345X03/wf-form4_165300021470983.xml…